Literature DB >> 11576028

Neuropsychological performance in long-term cannabis users.

H G Pope1, A J Gruber, J I Hudson, M A Huestis, D Yurgelun-Todd.   

Abstract

BACKGROUND: Although cannabis is the most widely used illicit drug in the United States, its long-term cognitive effects remain inadequately studied.
METHODS: We recruited individuals aged 30 to 55 years in 3 groups: (1) 63 current heavy users who had smoked cannabis at least 5000 times in their lives and who were smoking daily at study entry; (2) 45 former heavy users who had also smoked at least 5000 times but fewer than 12 times in the last 3 months; and (3) 72 control subjects who had smoked no more than 50 times in their lives. Subjects underwent a 28-day washout from cannabis use, monitored by observed urine samples. On days 0, 1, 7, and 28, we administered a neuropsychological test battery to assess general intellectual function, abstraction ability, sustained attention, verbal fluency, and ability to learn and recall new verbal and visuospatial information. Test results were analyzed by repeated-measures regression analysis, adjusting for potentially confounding variables.
RESULTS: At days 0, 1, and 7, current heavy users scored significantly below control subjects on recall of word lists, and this deficit was associated with users' urinary 11-nor-9-carboxy-Delta9-tetrahydrocannabinol concentrations at study entry. By day 28, however, there were virtually no significant differences among the groups on any of the test results, and no significant associations between cumulative lifetime cannabis use and test scores.
CONCLUSION: Some cognitive deficits appear detectable at least 7 days after heavy cannabis use but appear reversible and related to recent cannabis exposure rather than irreversible and related to cumulative lifetime use.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11576028     DOI: 10.1001/archpsyc.58.10.909

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  193 in total

1.  Spatial working memory in heavy cannabis users: a functional magnetic resonance imaging study.

Authors:  Gen Kanayama; Jadwiga Rogowska; Harrison G Pope; Staci A Gruber; Deborah A Yurgelun-Todd
Journal:  Psychopharmacology (Berl)       Date:  2004-06-16       Impact factor: 4.530

Review 2.  Clinical implications and methodological challenges in the study of the neuropsychological correlates of cannabis, stimulant, and opioid abuse.

Authors:  Antonio Verdejo-García; Francisca López-Torrecillas; Carmen Orozco Giménez; Miguel Pérez-García
Journal:  Neuropsychol Rev       Date:  2004-03       Impact factor: 7.444

3.  Functional connectivity in brain networks underlying cognitive control in chronic cannabis users.

Authors:  Ian H Harding; Nadia Solowij; Ben J Harrison; Michael Takagi; Valentina Lorenzetti; Dan I Lubman; Marc L Seal; Christos Pantelis; Murat Yücel
Journal:  Neuropsychopharmacology       Date:  2012-04-25       Impact factor: 7.853

4.  Altered parahippocampal functioning in cannabis users is related to the frequency of use.

Authors:  Benjamin Becker; Daniel Wagner; Euphrosyne Gouzoulis-Mayfrank; Elmar Spuentrup; Jörg Daumann
Journal:  Psychopharmacology (Berl)       Date:  2010-03-19       Impact factor: 4.530

5.  Effects of chronic marijuana use on brain activity during monetary decision-making.

Authors:  Jatin G Vaidya; Robert I Block; Daniel S O'Leary; Laura B Ponto; Mohamed M Ghoneim; Antoine Bechara
Journal:  Neuropsychopharmacology       Date:  2011-09-28       Impact factor: 7.853

Review 6.  State of the art treatments for cannabis dependence.

Authors:  Itai Danovitch; David A Gorelick
Journal:  Psychiatr Clin North Am       Date:  2012-04-10

7.  Contributions of ethnicity to differential item functioning of cannabis abuse and dependence symptoms.

Authors:  Ian R Gizer; David A Gilder; Philip Lau; Ting Wang; Kirk C Wilhelmsen; Cindy L Ehlers
Journal:  J Stud Alcohol Drugs       Date:  2013-03       Impact factor: 2.582

Review 8.  Pharmacokinetics and pharmacodynamics of cannabinoids.

Authors:  Franjo Grotenhermen
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

9.  Impact of Cannabis Use on the Development of Psychotic Disorders.

Authors:  Samuel T Wilkinson; Rajiv Radhakrishnan; Deepak Cyril D'Souza
Journal:  Curr Addict Rep       Date:  2014-06-01

10.  Cannabis use and neurocognitive functioning in a non-clinical sample of users.

Authors:  April D Thames; Natalie Arbid; Philip Sayegh
Journal:  Addict Behav       Date:  2014-02-06       Impact factor: 3.913

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.